Advanced Glycation End Products and Oxidative Stress in Type 2 Diabetes Mellitus

被引:798
|
作者
Nowotny, Kerstin [1 ]
Jung, Tobias [1 ]
Hoehn, Annika [1 ]
Weber, Daniela [1 ]
Grune, Tilman [1 ]
机构
[1] German Inst Human Nutr Potsdam Rehbrucke, Dept Mol Toxicol, Arthur Scheunert Allee 114-116, D-14558 Nuthetal, Germany
来源
BIOMOLECULES | 2015年 / 5卷 / 01期
关键词
advanced glycation end products; oxidative stress; type 2 diabetes mellitus; insulin resistance; cell dysfunction; diabetic complications;
D O I
10.3390/biom5010194
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Type 2 diabetes mellitus (T2DM) is a very complex and multifactorial metabolic disease characterized by insulin resistance and cell failure leading to elevated blood glucose levels. Hyperglycemia is suggested to be the main cause of diabetic complications, which not only decrease life quality and expectancy, but are also becoming a problem regarding the financial burden for health care systems. Therefore, and to counteract the continually increasing prevalence of diabetes, understanding the pathogenesis, the main risk factors, and the underlying molecular mechanisms may establish a basis for prevention and therapy. In this regard, research was performed revealing further evidence that oxidative stress has an important role in hyperglycemia-induced tissue injury as well as in early events relevant for the development of T2DM. The formation of advanced glycation end products (AGEs), a group of modified proteins and/or lipids with damaging potential, is one contributing factor. On the one hand it has been reported that AGEs increase reactive oxygen species formation and impair antioxidant systems, on the other hand the formation of some AGEs is induced per se under oxidative conditions. Thus, AGEs contribute at least partly to chronic stress conditions in diabetes. As AGEs are not only formed endogenously, but also derive from exogenous sources, i.e., food, they have been assumed as risk factors for T2DM. However, the role of AGEs in the pathogenesis of T2DM and diabetic complicationsif they are causal or simply an effectis only partly understood. This review will highlight the involvement of AGEs in the development and progression of T2DM and their role in diabetic complications.
引用
收藏
页码:194 / 222
页数:29
相关论文
共 50 条
  • [1] Dietary advanced glycation end products restriction diminishes inflammation markers and oxidative stress in patients with type 2 diabetes mellitus
    Luevano-Contreras, Claudia
    Garay-Sevilla, Ma. Eugenia
    Wrobel, Kazimierz
    Malacara, Juan M.
    Wrobel, Katarzyna
    JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION, 2013, 52 (01) : 22 - 26
  • [2] Low bone turnover is associated with advanced glycation end-products, oxidative stress, and inflammation induced by type 2 diabetes mellitus
    Shi, Peipei
    Gong, He
    Lyu, Linwei
    Liu, Shuyu
    Jia, Shaowei
    Li, Chenchen
    Wu, Xiaodan
    Li, Xitong
    FASEB JOURNAL, 2024, 38 (15):
  • [3] Advanced Glycation End Products and Their Effect on Vascular Complications in Type 2 Diabetes Mellitus
    Lee, Jeongmin
    Yun, Jae-Seung
    Ko, Seung-Hyun
    NUTRIENTS, 2022, 14 (15)
  • [4] Association of advanced glycation end products with diabetic retinopathy in type 2 diabetes mellitus
    Ying, Lingwen
    Shen, Yun
    Zhang, Yang
    Wang, Yikun
    Liu, Yong
    Yin, Jun
    Wang, Yufei
    Yin, Jingrong
    Zhu, Wei
    Bao, Yuqian
    Zhou, Jian
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 177
  • [5] Decreased plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus: association with oxidative stress and metabolic control
    Santilli, F.
    Devangelio, E.
    Formoso, G.
    Ferroni, P.
    Bucciarelli, L.
    Ciabattoni, G.
    Consoli, A.
    Davi, G.
    EUROPEAN HEART JOURNAL, 2006, 27 : 392 - 393
  • [6] Advanced glycation end products and adipocytokines and oxidative stress in placental tissues of pregnant women with gestational diabetes mellitus
    Li, Hongxia
    Dong, Aihong
    Lv, Xiaoxia
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 18 (01) : 685 - 691
  • [7] Association of advanced glycation end products (AGEs) with endothelial dysfunction, oxidative stress in gestational diabetes mellitus (GDM)
    Krishnasamy, Sundar
    Rajaraman, Barathi
    Ravi, Vidya
    Rajagopal, Rashmi
    Ganeshprasad, Arunkumar
    Kuppuswamy, Ashok Ayyappa
    Pathak, Atima
    Dhevasena, C. S.
    Swaminathan, Krishnan
    Sundaresan, Mohanraj
    Ramadas, Nirupama
    Vedantham, Srinivasan
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2020, 40 (02) : 276 - 282
  • [8] Association of advanced glycation end products (AGEs) with endothelial dysfunction, oxidative stress in gestational diabetes mellitus (GDM)
    Sundar Krishnasamy
    Barathi Rajaraman
    Vidya Ravi
    Rashmi Rajagopal
    Arunkumar Ganeshprasad
    Ashok Ayyappa Kuppuswamy
    Atima Pathak
    C. S. Dhevasena
    Krishnan Swaminathan
    Mohanraj Sundaresan
    Nirupama Ramadas
    Srinivasan Vedantham
    International Journal of Diabetes in Developing Countries, 2020, 40 : 276 - 282
  • [9] Skin advanced glycation end products as a screening tool of neuropathy in type 2 diabetes mellitus
    Papachristou, Stella
    Pafili, Kalliopi
    Trypsianis, Grigorios
    Papazoglou, Dimitrios
    Vadikolias, Konstantinos
    Papanas, Nikolaos
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2022, 36 (12)
  • [10] Assessment of Pentosidine as a Marker for Advanced Glycation End Products in Type 2 Diabetes Mellitus Patients
    Jaishankar, Sarath Kumar Jaganathan
    Murali, Amrutha
    Marzooka, Amrin
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2020, 14 (02)